- Consumables
- Instruments
Blood Grouping Reagent Market size was valued at USD 2,541 billion in 2022 and is poised to grow at a CAGR of 7.73% from 2023-29. Blood grouping reagents are solutions used to determine ABO, Rhesus, Kell, and MNS blood groups. These divisions of human blood are all depending on whether or not the red blood cells' surfaces contain particular antigens. In the test, red blood cells that carry a specific antigen clump together as a result of the reagents indicating positive results. One of the main drivers of the blood grouping market is the rising need for organ and blood transplants. According to the American Red Cross, an estimated 6.8 million people in the U.S. donate blood with almost 13.6 million units of whole blood and RBCs collected in a year further increasing the blood grouping market. The increased number of patients with platelet erectile dysfunction like thrombocytopenia, cancer, myeloproliferative disorders (MPDs), myelodysplasia, and paraproteinemia is expected to create lucrative opportunities for further development in the market owing to the imperative need for surgeons and doctors to detect the biochemical composition to form a link between disease and druggable target.
Based on the technique outlook, PCR-based and microarray techniques are dominating the market owing to the low cost, ease, and versatility in, in vitro methods for amplifying defined target RBC polymorphic regions. Moreover, the prevalence of anaemia, kidney diseases, and increased accident rates have created a large demand for the blood grouping market. According to WHO, 1.3 million people die each year, along with 20-50 million people suffering injuries, with many incurring a disability as a result of injury from road traffic crashes further increasing the demand for blood grouping reagent market. Furthermore, based on test type, antibody screening is used extensively for documenting exposure to infectious agents, assessing immune status to microorganisms determining the cause of a transfusion reaction of an organ transplant, and tracking the gradual progression of infection or autoimmune disease. The development of new infrastructure, urbanization, and the rise in government campaigns to raise public awareness of the benefits of voluntary blood and organ donations have led to the burgeon of the blood-g grouping reagent market. Furthermore, the rising prevalence of chronic diseases and the accelerating demand for early detection by blood grouping is leading to market growth.
Blood Grouping Reagents Market Key Developments:
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Factors such as rising in the prevalence rate of various diseases, dire need for the blood during surgical procedures, rise in the government initiatives about necessity of the donation of blood, safe blood transfusion, campaigns on blood donation are propelling the growth of blood grouping reagents market. However, lacking in the awareness, lack of trained and skilled professionals which may lead to risks in transfusion hence, diminishing the growth of blood bank reagents globally.
The blood grouping reagents market size was valued at USD 2,541 billion in 2022
The blood grouping reagents market key players are: Grifols, S.A. (Spain) and Bio-Rad Laboratories, Inc. (U.S.) Immucor, Inc. (U.S.) Quotient, Ltd. (U.S.) Novacyt Group (France) Ortho Clinical Diagnostics, Inc. (U.S.) BAG Healthcare GmbH (Germany) Day medical SA (Switzerland) Rapid Labs (U.K.) AXO Science (France) DIAGAST (France)
The blood grouping reagents market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
1. Executive Summary |
2. Global Blood Grouping Reagents Market Introduction |
2.1. Global Blood Grouping Reagents Market Taxonomy |
2.2. Global Blood Grouping Reagents Market Definitions |
2.2.1. Product |
2.2.2. Technique |
2.2.3. Test Type |
2.2.4. End-User |
3. Global Blood Grouping Reagents Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Blood Grouping Reagents Market Dynamic Factors - Impact Analysis |
3.6. Global Blood Grouping Reagents Market Regulations |
3.6.1. U.S. |
3.6.2. Europe |
3.7. Global Blood Grouping Reagents Market Trends |
4. Global Blood Grouping Reagents Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 |
4.1. Market Analysis, 2012 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Oppurtunity Analysis |
5. Global Blood Grouping Reagents Market, By Product, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
5.1. Consumables |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Instruments |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Blood Grouping Reagents Market Forecast, By Technique, 2018 - 2022 and Forecast, 2023 - 2029 |
6.1. PCR-based and Microarray Technique |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Assay-Based Techniques |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Massively Parallel Sequencing Techniques |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Other Techniques |
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. Global Blood Grouping Reagents Market Forecast, By Test Type, 2018 - 2022 and Forecast, 2023 - 2029 |
7.1. Antibody Screening |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. HLA Typing |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Cross-Matching Tests |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. ABO Blood Tests |
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Antigen Typing |
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. Global Blood Grouping Reagents Market Forecast, By End-Use, 2018 - 2022 and Forecast, 2023 - 2029 |
8.1. Hospitals |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Blood Banks |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Clinical Laboratories |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
9. Global Blood Grouping Reagents Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
9.1. North America |
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia-Pacific |
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Latin America |
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Middle East and Africa |
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
9.6. Global Blood Grouping Reagents Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Region, 2023 - 2029 |
10. North America Blood Grouping Reagents Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
10.1. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Consumables |
10.1.2. Instruments |
10.2. Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. PCR-based and Microarray Technique |
10.2.2. Assay-Based Techniques |
10.2.3. Massively Parallel Sequencing Techniques |
10.2.4. Other Techniques |
10.3. Test Type Analysis, 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.3.1. Antibody Screening |
10.3.2. HLA Typing |
10.3.3. Cross-Matching Tests |
10.3.4. ABO Blood Tests |
10.3.5. Antigen Typing |
10.4. End -Use Analysis, 2012- 2016 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.4.1. Hospitals |
10.4.2. Blood Banks |
10.4.3. Clinical Laboratories |
10.5. Country Analysis 2016 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.5.1. U.S. |
10.5.2. Canada |
10.6. North America Blood Grouping Reagents Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2018 |
10.7. North America Blood Grouping Reagents Market Dynamics Trends |
11. Europe Blood Grouping Reagents Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
11.1. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Consumables |
11.1.2. Instruments |
11.2. Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. PCR-based and Microarray Technique |
11.2.2. Assay-Based Techniques |
11.2.3. Massively Parallel Sequencing Techniques |
11.2.4. Other Techniques |
11.3. Test Type Analysis, 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.3.1. Antibody Screening |
11.3.2. HLA Typing |
11.3.3. Cross-Matching Tests |
11.3.4. ABO Blood Tests |
11.3.5. Antigen Typing |
11.4. End -Use Analysis, 2012- 2016 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.4.1. Hospitals |
11.4.2. Blood Banks |
11.4.3. Clinical Laboratories |
11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.5.1. Germany |
11.5.2. UK |
11.5.3. France |
11.5.4. Spain |
11.5.5. Italy |
11.5.6. Russia |
11.5.7. Poland |
11.5.8. Rest of Europe |
11.6. Europe Blood Grouping Reagents Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2023 - 2029 |
11.7. Europe Blood Grouping Reagents Market Dynamics Trends |
12. Asia-Pacific Blood Grouping Reagents Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
12.1. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Consumables |
12.1.2. Instruments |
12.2. Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. PCR-based and Microarray Technique |
12.2.2. Assay-Based Techniques |
12.2.3. Massively Parallel Sequencing Techniques |
12.2.4. Other Techniques |
12.3. Test Type Analysis, 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.3.1. Antibody Screening |
12.3.2. HLA Typing |
12.3.3. Cross-Matching Tests |
12.3.4. ABO Blood Tests |
12.3.5. Antigen Typing |
12.4. End -Use Analysis, 2012- 2016 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.4.1. Hospitals |
12.4.2. Blood Banks |
12.4.3. Clinical Laboratories |
12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.5.1. Japan |
12.5.2. China |
12.5.3. India |
12.5.4. ASEAN |
12.5.5. Australia & New Zealand |
12.5.6. Rest of Asia-Pacific |
12.6. Asia-Pacific Blood Grouping Reagents Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2023 - 2029 |
12.7. Asia-Pacific Blood Grouping Reagents Market Dynamics – Trends |
13. Latin America Blood Grouping Reagents Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
13.1. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Consumables |
13.1.2. Instruments |
13.2. Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.2.1. PCR-based and Microarray Technique |
13.2.2. Assay-Based Techniques |
13.2.3. Massively Parallel Sequencing Techniques |
13.2.4. Other Techniques |
13.3. Test Type Analysis, 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.3.1. Antibody Screening |
13.3.2. HLA Typing |
13.3.3. Cross-Matching Tests |
13.3.4. ABO Blood Tests |
13.3.5. Antigen Typing |
13.4. End -Use Analysis, 2018- 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.4.1. Hospitals |
13.4.2. Blood Banks |
13.4.3. Clinical Laboratories |
13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.5.1. Brazil |
13.5.2. Mexico 13.5.3. Argentina |
13.5.4. Venezuela |
13.5.5. Rest of Latin America |
13.6. Latin America Blood Grouping Reagents Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2023 - 2029 |
13.7. Latin America Blood Grouping Reagents Market Dynamics Trends |
14. Middle East and Africa Blood Grouping Reagents Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
14.1. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.1.1. Consumables |
14.1.2. Instruments |
14.2. Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.2.1. PCR-based and Microarray Technique |
14.2.2. Assay-Based Techniques |
14.2.3. Massively Parallel Sequencing Techniques |
14.2.4. Other Techniques |
14.3. Test Type Analysis, 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.3.1. Antibody Screening |
14.3.2. HLA Typing |
14.3.3. Cross-Matching Tests |
14.3.4. ABO Blood Tests |
14.3.5. Antigen Typing |
14.4. End -Use Analysis, 2018- 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.4.1. Hospitals |
14.4.2. Blood Banks |
14.4.3. Clinical Laboratories |
14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
14.5.1. Gulf Cooperation Council (GCC) Countries |
14.5.2. Israel |
14.5.3. South Africa |
14.5.4. Rest of MEA |
14.6. MEA Blood Grouping Reagents Market - Opportunity Analysis Index, By Product, By Technique, By Test Type, By End - Use and Country, 2023 - 2029 |
14.7. MEA Blood Grouping Reagents Market Dynamics Trends |
15. Competition Landscape |
15.1. Strategic Dashboard of Top Market Players |
15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
15.2.1. Grifols, S.A. (Spain) |
15.2.2. Bio-Rad Laboratories, Inc. (U.S.) |
15.2.3. Immucor, Inc. (U.S.) |
15.2.4. Quotient, Ltd. (U.S.) |
15.2.5. Novacyt Group (France) |
15.2.6. Ortho Clinical Diagnostics, Inc. (U.S.) |
15.2.7. BAG Healthcare GmbH (Germany) |
15.2.8. Day medical SA (Switzerland) |
15.2.9. Rapid Labs (U.K.) |
15.2.10. AXO Science (France) |
15.2.11. DIAGAST (France) |
16. Research Methodology |
17. Key Assumptions and Acronyms |